instruction stringlengths 35 191 | input stringlengths 0 31.3k | output stringlengths 0 1.83k |
|---|---|---|
Do Abaloparatide and Acebutolol interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Acebutolol. | Minor | |
Can Abaloparatide and Aldesleukin be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Aldesleukin? | Minor | |
How do Abaloparatide and Aliskiren interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Aliskiren. | Minor | |
Do Abaloparatide and Ambrisentan interact with each other? | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. | |
How severe is the interaction between Abaloparatide and Ambrisentan? | Minor | |
How do Abaloparatide and Amifostine interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Amifostine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Amiloride? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amiloride. | Minor | |
Do Abaloparatide and Amiodarone interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amiodarone. | Minor | |
Can Abaloparatide and Amlodipine be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amlodipine. | Minor | |
How do Abaloparatide and Amobarbital interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The use of barbiturates may increase hypotension. 1,2 Therefore, the concomitant administration of barbiturates and hypotensive agents may lead to dangerous hypotension due to additive effects. |
Rate the interaction severity between Abaloparatide and Amobarbital. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Moderate |
Is there an interaction between Abaloparatide and Amphotericin B? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Amphotericin B? | Minor | |
Is there an interaction between Abaloparatide and Amyl Nitrite? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Amyl Nitrite? | Minor | |
Can Abaloparatide and Apomorphine be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the severity of the interaction when Abaloparatide and Apomorphine are co-administered? | Minor | |
Do Abaloparatide and Aripiprazole lauroxil interact with each other? | Aripiprazole may cause orthostatic hypotension through antagonism of the α1-adrenergic receptor. 3,2,4 Cases of orthostatic hypotension, postural dizziness, and syncope have been reported with the short-term use of aripiprazole in clinical trials. The risk for developing a decrease in blood pressure may be enhanced wit... | |
What is the risk level of combining Abaloparatide and Aripiprazole lauroxil? | Minor | |
How do Abaloparatide and Aripiprazole interact? | Aripiprazole may cause orthostatic hypotension through antagonism of the α1-adrenergic receptor. 3,2,4 Cases of orthostatic hypotension, postural dizziness, and syncope have been reported with the short-term use of aripiprazole in clinical trials. The risk for developing a decrease in blood pressure may be enhanced wit... | |
Rate the interaction severity between Abaloparatide and Aripiprazole. | Minor | |
Do Abaloparatide and Arsenic trioxide interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Arsenic trioxide. | Minor | |
Do Abaloparatide and Atenolol interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Atenolol. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Avanafil interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The subject drug is a phosphodiesterase 5 inhibitor which can lower blood pressure. 1 The affected drug can cause hypotension, particularly orthostatic hypotension. Concomitant administration of these medications may lead to an increased risk of hypotension and orthostatic hypotension. |
How severe is the interaction between Abaloparatide and Avanafil? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Azilsartan medoxomil interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Azilsartan medoxomil. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Benazepril interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Benazepril? | Minor | |
How do Abaloparatide and Betaxolol interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Betaxolol. | Minor | |
Is there an interaction between Abaloparatide and Bisoprolol? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Bisoprolol? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Bosentan? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. |
How severe is the interaction between Abaloparatide and Bosentan? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Bretylium? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Bretylium? | Minor | |
Is there an interaction between Abaloparatide and Bromocriptine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
How severe is the interaction between Abaloparatide and Bromocriptine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Can Abaloparatide and Bumetanide be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Bumetanide. | Minor | |
Can Abaloparatide and Bupivacaine be taken together? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
End of preview. Expand in Data Studio
No dataset card yet
- Downloads last month
- 12